{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06112353",
            "orgStudyIdInfo": {
                "id": "2295"
            },
            "secondaryIdInfos": [
                {
                    "id": "Field 100931",
                    "type": "OTHER",
                    "domain": "Merck Investigator Initiated Studies Program (MISP)"
                }
            ],
            "organization": {
                "fullName": "University of California, Irvine",
                "class": "OTHER"
            },
            "briefTitle": "Neuromuscular Blockade Comparison for GI-2 Recovery After Bowel Resection",
            "officialTitle": "Sugammadex VS Neostigmine and Glycopyrrolate Reversal of Neuromuscular Relaxation For Time to Return of Bowel Function After Bowel Resection: Prospective, Randomized, Triple-blinded Clinical Trial For Quality Improvement",
            "therapeuticArea": [
                "Other"
            ],
            "study": "neuromuscular-blockade-comparison-for-gi-recovery-after-bowel-resection"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-03",
            "overallStatus": "NOT_YET_RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-04",
                "type": "ESTIMATED"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-11",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-12",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-10-20",
            "studyFirstSubmitQcDate": "2023-10-31",
            "studyFirstPostDateStruct": {
                "date": "2023-11-01",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-03-28",
            "lastUpdatePostDateStruct": {
                "date": "2024-04-01",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Robert Ryan Field",
                "investigatorTitle": "Associate Clinical Professor, Dept of Anesthesiology & Perioperative Medicine",
                "investigatorAffiliation": "University of California, Irvine"
            },
            "leadSponsor": {
                "name": "University of California, Irvine",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "Merck Sharp & Dohme LLC",
                    "class": "INDUSTRY"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false,
            "isUsExport": true
        },
        "descriptionModule": {
            "briefSummary": "The purpose of this research study is to see the outcome of Sugammadex versus Neostigmine with Glycopyrrolate in colorectal surgery as it relates to its effects on post-surgical time (in hours) to first bowel movement and tolerance for solid food (GI-2 recovery) following bowel resection surgery",
            "detailedDescription": "Neuromuscular blocking agents are essential during surgical procedures to paralyze the body to avoid unnecessary movement during surgery. There are various medications, such as Sugammadex that are later used to reverse the effects of the neuromuscular blockade. The U.S. performs approximately 320,000 colectomies per year for benign and malignant conditions such as Ulcerative Colitis (UC). Bowel resection surgery removes a portion of small or large intestine. Currently, there is little available prospective outcomes data regarding the use of Sugammadex versus Neostigmine with Glycopyrrolate in colorectal surgery as it relates to its effects on post-surgical time (hour) to first bowel movement and tolerance for solid food (aka GI-2 recovery) following bowel resection surgery. The study team will be conducting a randomized triple-blind study (patient's assigned group is hidden from the patient, provider, and research team). Randomization is created by using an electronic randomizer. Upon consent, the patient's assignment (per the randomizer) will be submitted to the Investigational Drug Service (IDS) Pharmacy by a department employee with no direct patient interaction."
        },
        "conditionsModule": {
            "conditions": [
                "Intestinal Disease"
            ],
            "keywords": [
                "Laparoscopic Bowel Resection",
                "Sugammadex",
                "Neostigmine",
                "Glycopyrrolate",
                "GI-2"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE4"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "TRIPLE",
                    "maskingDescription": "Triple",
                    "whoMasked": [
                        "PARTICIPANT",
                        "CARE_PROVIDER",
                        "INVESTIGATOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 128,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Neostigmine plus Glycopyrrolate",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "0.07 mg/kg Neostigmine plus 0.014 mg/kg glycopyrrolate\n\n2 syringes numbered 1 and 2\n\n1. Syringe #1: Glycopyrrolate\n2. Syringe #2: Neostigmine",
                    "interventionNames": [
                        "Drug: Neostigmine Injectable Solution"
                    ]
                },
                {
                    "label": "Sugammadex",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "2.0 mg/kg of Sugammadex plus saline equivalent\n\n2 syringes numbered 1 and 2\n\n1. Syringe #1: 0.9% sodium chloride\n2. Syringe #2: : full Sugammadex dose + 0.9 sodium chloride (QS to match volume)",
                    "interventionNames": [
                        "Drug: Sugammadex injection"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Neostigmine Injectable Solution",
                    "description": "Examine GI-2 recovery",
                    "armGroupLabels": [
                        "Neostigmine plus Glycopyrrolate"
                    ],
                    "otherNames": [
                        "Neostigmine plus Glycopyrrolate",
                        "Group B"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Sugammadex injection",
                    "description": "Examine GI-2 recovery",
                    "armGroupLabels": [
                        "Sugammadex"
                    ],
                    "otherNames": [
                        "Sugammadex",
                        "Group A"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "GI-2 Recovery",
                    "description": "GI-2 recovery as defined as hour to first bowel movement and toleration of oral diet",
                    "timeFrame": "Up to 24 hours post surgery"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Cost of Stay",
                    "description": "Total cost of surgical stay",
                    "timeFrame": "From hospital admission to discharge, up to 30 days"
                },
                {
                    "measure": "Length of Stay",
                    "description": "Total time patient is at hospital",
                    "timeFrame": "From hospital admission to discharge, up to 60 days"
                },
                {
                    "measure": "Morbidity & Mortality Rate",
                    "description": "Symptomatic disease presence and death",
                    "timeFrame": "30 days post surgery"
                },
                {
                    "measure": "Number of Participants Experiencing Post Reversal Bradycardia",
                    "description": "Slowed heart rate following reversal",
                    "timeFrame": "Post surgically but prior to PACU discharge, up to 24 hours"
                },
                {
                    "measure": "Duration of PACU Stay",
                    "description": "Time in PACU, not owing to bed availability",
                    "timeFrame": "From surgical end time to PACU discharge, up to 24 hours"
                },
                {
                    "measure": "Time to Out of Bed",
                    "description": "Time for patient to be able to get out of bed and walk post surgically",
                    "timeFrame": "Up to 24 hours post surgery"
                },
                {
                    "measure": "Amount of Fluid Administration",
                    "description": "IV fluid administration during surgery",
                    "timeFrame": "Intraoperative"
                },
                {
                    "measure": "Presence of Bowel Adhesion",
                    "description": "Scar tissue found in bowels",
                    "timeFrame": "Intraoperative"
                },
                {
                    "measure": "Number of Participants Experiencing PONV",
                    "description": "Post operative nausea and vomiting",
                    "timeFrame": "Postoperative to discharge, up to 1 week"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Age 18 or older\n* Laparoscopic bowel resection surgery under general anesthesia with nondepolarizing neuromuscular blockade with rocuronium or vecuronium, and requiring inpatient admission\n\nExclusion Criteria:\n\n* Allergy to Rocuronium, Vecuronium, or Sugammadex\n* Bowel resection surgery requiring an ostomy\n* No severe valvulopathy, no systolic heart failure with reduced ejection fraction (HFrEF), no coronary artery disease with positive stress test for ischemic regional wall motion abnormality\n* No autoimmune pulmonary disease, no severe pulmonary fibrosis, no severe pulmonary hypertension, no COPD with requirement of home oxygen, no pulmonary cancer of primary or metastatic origin\n* Creatinine Clearance (CrCl) of less than 30\n* Pregnancy\n* Incapable of providing consent or understanding the research project",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Paulette Mensah, BA",
                    "role": "CONTACT",
                    "phone": "714-456-8818",
                    "email": "pmensah@hs.uci.edu"
                },
                {
                    "name": "Robert R Field, MD",
                    "role": "CONTACT",
                    "phone": "714-506-5703",
                    "email": "fieldr@hs.uci.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Robert R Field, MD",
                    "affiliation": "Associate Clinical Professor",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "UC Irvine Medical Center",
                    "city": "Orange",
                    "state": "California",
                    "zip": "92868",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Paulette Mensah, BA",
                            "role": "CONTACT",
                            "phone": "714-456-8818",
                            "email": "pmensah@hs.uci.edu"
                        },
                        {
                            "name": "Robert R Field, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        },
                        {
                            "name": "Joseph C Carmichael, MD",
                            "role": "SUB_INVESTIGATOR"
                        },
                        {
                            "name": "Steven D Mills, MD",
                            "role": "SUB_INVESTIGATOR"
                        },
                        {
                            "name": "Skandan Shanmugan, MD",
                            "role": "SUB_INVESTIGATOR"
                        },
                        {
                            "name": "Valery C ilchez, MD",
                            "role": "SUB_INVESTIGATOR"
                        },
                        {
                            "name": "Matthew D Whealon, MD",
                            "role": "SUB_INVESTIGATOR"
                        },
                        {
                            "name": "Paulette Mensah, BA",
                            "role": "SUB_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.78779,
                        "lon": -117.85311
                    }
                }
            ]
        },
        "referencesModule": {
            "references": [
                {
                    "pmid": "28806470",
                    "type": "BACKGROUND",
                    "citation": "Hristovska AM, Duch P, Allingstrup M, Afshari A. Efficacy and safety of sugammadex versus neostigmine in reversing neuromuscular blockade in adults. Cochrane Database Syst Rev. 2017 Aug 14;8(8):CD012763. doi: 10.1002/14651858.CD012763."
                },
                {
                    "pmid": "28381944",
                    "type": "BACKGROUND",
                    "citation": "Briggs A, Goldberg J. Tips, Tricks, and Technique for Laparoscopic Colectomy. Clin Colon Rectal Surg. 2017 Apr;30(2):130-135. doi: 10.1055/s-0036-1597313."
                },
                {
                    "pmid": "32099426",
                    "type": "BACKGROUND",
                    "citation": "Deyhim N, Beck A, Balk J, Liebl MG. Impact of Sugammadex Versus Neostigmine/Glycopyrrolate on Perioperative Efficiency. Clinicoecon Outcomes Res. 2020 Jan 31;12:69-79. doi: 10.2147/CEOR.S221308. eCollection 2020."
                },
                {
                    "pmid": "33039637",
                    "type": "BACKGROUND",
                    "citation": "Gray PJ, Goldwag JL, Eid MA, Sacks OA, Wilson LR, Wilson MZ, Ivatury SJ. Does Bowel Function Change After Colectomy for Colon Malignancy? J Surg Res. 2021 Feb;258:283-288. doi: 10.1016/j.jss.2020.09.003. Epub 2020 Oct 8."
                },
                {
                    "pmid": "33534892",
                    "type": "BACKGROUND",
                    "citation": "Bhurwal A, Minacapelli CD, Patel A, Mutneja H, Goel A, Shah I, Bansal V, Brahmbhatt B, Das KM. Evaluation of a U.S. National Cohort to Determine Utilization in Colectomy Rates for Ulcerative Colitis Among Ethnicities. Inflamm Bowel Dis. 2022 Jan 5;28(1):54-61. doi: 10.1093/ibd/izab020."
                },
                {
                    "pmid": "19015469",
                    "type": "BACKGROUND",
                    "citation": "Ludwig K, Enker WE, Delaney CP, Wolff BG, Du W, Fort JG, Cherubini M, Cucinotta J, Techner L. Gastrointestinal tract recovery in patients undergoing bowel resection: results of a randomized trial of alvimopan and placebo with a standardized accelerated postoperative care pathway. Arch Surg. 2008 Nov;143(11):1098-105. doi: 10.1001/archsurg.143.11.1098."
                },
                {
                    "pmid": "34986061",
                    "type": "BACKGROUND",
                    "citation": "Deljou A, Soleimani J, Sprung J, Schroeder DR, Weingarten TN. Effects of Reversal Technique for Neuromuscular Paralysis on Time to Recovery of Bowel Function after Craniotomy. Am Surg. 2023 May;89(5):1605-1609. doi: 10.1177/00031348211058631. Epub 2022 Jan 5."
                },
                {
                    "pmid": "19222430",
                    "type": "BACKGROUND",
                    "citation": "Booij LH, van Egmond J, Driessen JJ, de Boer HD. In vivo animal studies with sugammadex. Anaesthesia. 2009 Mar;64 Suppl 1:38-44. doi: 10.1111/j.1365-2044.2008.05869.x."
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000007410",
                    "term": "Intestinal Diseases"
                }
            ],
            "ancestors": [
                {
                    "id": "D000005767",
                    "term": "Gastrointestinal Diseases"
                },
                {
                    "id": "D000004066",
                    "term": "Digestive System Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M10444",
                    "name": "Intestinal Diseases",
                    "asFound": "Intestinal Diseases",
                    "relevance": "HIGH"
                },
                {
                    "id": "M7255",
                    "name": "Digestive System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M8883",
                    "name": "Gastrointestinal Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC06",
                    "name": "Digestive System Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000006024",
                    "term": "Glycopyrrolate"
                },
                {
                    "id": "D000009388",
                    "term": "Neostigmine"
                }
            ],
            "ancestors": [
                {
                    "id": "D000002800",
                    "term": "Cholinesterase Inhibitors"
                },
                {
                    "id": "D000004791",
                    "term": "Enzyme Inhibitors"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000018678",
                    "term": "Cholinergic Agents"
                },
                {
                    "id": "D000018377",
                    "term": "Neurotransmitter Agents"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000010277",
                    "term": "Parasympathomimetics"
                },
                {
                    "id": "D000001337",
                    "term": "Autonomic Agents"
                },
                {
                    "id": "D000018373",
                    "term": "Peripheral Nervous System Agents"
                },
                {
                    "id": "D000000759",
                    "term": "Adjuvants, Anesthesia"
                },
                {
                    "id": "D000018727",
                    "term": "Muscarinic Antagonists"
                },
                {
                    "id": "D000018680",
                    "term": "Cholinergic Antagonists"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M21860",
                    "name": "Pharmaceutical Solutions",
                    "relevance": "LOW"
                },
                {
                    "id": "M12333",
                    "name": "Neostigmine",
                    "asFound": "Chronic Lymphocytic Leukemia",
                    "relevance": "HIGH"
                },
                {
                    "id": "M9130",
                    "name": "Glycopyrrolate",
                    "asFound": "Pain Relief",
                    "relevance": "HIGH"
                },
                {
                    "id": "M6040",
                    "name": "Cholinesterase Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M7951",
                    "name": "Enzyme Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M20758",
                    "name": "Cholinergic Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M20504",
                    "name": "Neurotransmitter Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M4107",
                    "name": "Anesthetics",
                    "relevance": "LOW"
                },
                {
                    "id": "M4089",
                    "name": "Adjuvants, Anesthesia",
                    "relevance": "LOW"
                },
                {
                    "id": "M20801",
                    "name": "Muscarinic Antagonists",
                    "relevance": "LOW"
                },
                {
                    "id": "M20760",
                    "name": "Cholinergic Antagonists",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "PhSol",
                    "name": "Pharmaceutical Solutions"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "AdjAn",
                    "name": "Adjuvants, Anesthesia"
                },
                {
                    "abbrev": "CNSDep",
                    "name": "Central Nervous System Depressants"
                }
            ]
        }
    },
    "hasResults": false
}